MRI Techniques Can Predict Future Sudden Cardiac Death
|
By MedImaging International staff writers Posted on 19 Jul 2022 |

Sudden cardiac death (SCD) accounts for 50% of all cardiovascular deaths in the US, claiming more than 300,000 American lives annually, according to the American Heart Association. Currently, an implantable cardioverter-defibrillator (ICD) - a small, battery-powered device placed in the chest to detect and stop irregular heart rhythms - is the primary means of preventing SCD in high-risk patients. The device continuously monitors the heart rhythm and delivers electric shocks, when needed, to restore a regular heart rhythm. The battery life of an ICD is typically between five to seven years. Now, a new study has found that adults with abnormal heart metabolism are up to three times more likely to experience life-threatening arrhythmias (an irregular heart rhythm), and magnetic resonance imaging (MRI) techniques could be used to detect the condition and predict future SCD.
In the small, but rigorous study, researchers at the Johns Hopkins University School of Medicine (Baltimore, MD, USA) measured the levels of adenosine triphosphate (ATP), the primary chemical cellular energy source, in the hearts of 46 people prior to getting an ICD for primary prevention. The cardiac ATP levels were measured on clinical MRI scanners using a magnetic resonance spectroscopy (MRS) technique developed at Johns Hopkins Medicine, to determine which patients had abnormal ATP metabolism. All patients were followed up every three to six months for an average of 10 years to determine which patients had appropriate ICD firings for life-threatening arrhythmias.
Results showed that people with low cardiac ATP levels (impaired metabolism) had a three-fold higher risk of sudden cardiac death (if not saved by ICD intervention) compared to those with normal ATP metabolism. This was still the case when adjusted for low left ventricular ejection fraction, the metric currently used to determine the need for a primary prevention ICD. The researchers say the study findings could complement current approaches and lead to better predictions for who is most likely to need, or not need an ICD. However, they stress, that more studies are needed to assess different and larger populations.
“We believe this is the first time that impaired cardiac metabolism in people has been linked to an increased risk of life-threatening arrhythmias or sudden cardiac death,” said study senior author Robert Weiss, M.D., professor of medicine at the Johns Hopkins University School of Medicine. “This could open a window for a whole new approach, a metabolic approach for treating or preventing severe arrhythmias, which is something that is not currently available in cardiology.”
“Over seven years, 60-70% of these devices never discharge to save a life,” added T. Jake Samuel, Ph.D., first author of the study and fellow in cardiology at Johns Hopkins Medicine. “We’re spending billions of dollars a year on ICDs that are implanted and have procedural and post-procedural risks. There is a need for non-invasive approaches to better assess risk for who needs or doesn’t need an ICD to prevent sudden cardiac death in people.”
Related Links:
Johns Hopkins University School of Medicine
Latest MRI News
- Rapid AI System Detects and Classifies Brain Tumor Subtypes on MRI
- Advanced MRI Reveals Structural Brain Changes Linked to Better Cognitive Health
- Cardiac MRI Detects Hidden Heart Dysfunction After Heart Attack
- AI Tool Reveals Cortical Lesions on Standard MRI in Multiple Sclerosis
- AI Reconstruction Tool Speeds Dynamic Breast MRI and Improves Cancer Detection
- International Study Assesses AI for Prostate Cancer MRI Interpretation
- AI Approach Could Shorten Advanced Brain MRI Scans by Up to 90%
- Cardiac MRI Measure Improves Risk Prediction in Tricuspid Regurgitation
- AI System Improves Accuracy of Cardiac MRI Interpretation
- Deep Learning Model Predicts Alzheimer’s Disease Outcomes from Baseline MRI
- Blood-Brain Barrier Imaging Adds Risk Insight to Standard Stroke MRI
- AI Body Composition MRI Analysis Predicts Cardiometabolic Disease Risk
- AI MRI Tool Quantifies Muscle Fat to Assess Cardiometabolic Risk
- Advanced MRI Visualizes CSF Motion Changes After Mild Traumatic Brain Injury
- MRI Tool Enables Long-Term Tracking of Transplanted Cardiac Cells
- MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
Channels
Radiography
view channel
Computational X-Ray Technique Enables High-Resolution, Low-Dose Radiography
Reducing radiation in medical X-ray imaging remains a persistent challenge because dose reductions often degrade spatial resolution and diagnostic confidence. This is especially critical in pediatrics,... Read more
AI Tool Predicts Five-Year Breast Cancer Risk from Mammograms
Breast cancer risk assessment during routine screening is difficult because many women who develop the disease have no known genetic mutations or family history. Static risk tools provide limited discrimination... Read moreUltrasound
view channel
Simple 2D Ultrasound Tool Accurately Estimates Placental Volume
Stillbirth remains a major cause of perinatal loss, with about 21,000 cases annually in the United States. Although placental abnormalities are linked to adverse pregnancy outcomes, routine monitoring... Read more
Portable 3D Ultrasound System Enables Reproducible Breast Cancer Monitoring
Breast cancer can develop between annual mammograms, and these interval cancers account for 20% to 30% of cases and tend to be more aggressive. The challenge is pronounced in people with dense breast tissue.... Read moreNuclear Medicine
view channel
Radiotherapy Professionals Embrace AI as a Clinical Support Tool
Radiotherapy planning requires precise identification of organs at risk near a tumor, but manual contouring is repetitive and time-consuming, often delaying plan completion and straining specialist capacity.... Read more
Second PSMA PET Identifies Disease in More Than Half of Negative Cases
Biochemical recurrence of prostate cancer after prostatectomy or radiation can be difficult to localize when imaging is negative. Uncertain disease sites may delay salvage therapy and expose patients to... Read moreGeneral/Advanced Imaging
view channel
PET/CT Improves Diagnosis and Management of Fever of Unknown Origin
Fever of unknown origin (FUO) is persistent fever without an identifiable cause and remains difficult to diagnose because potential etiologies are broad and no single gold-standard pathway exists.... Read more
New PE-RADS Framework Standardizes Pulmonary Embolism Imaging Reports
Pulmonary embolism is a sudden blockage of the lung’s blood vessels that reduces pulmonary blood flow, can strain the right hear,t and may be fatal if untreated. Patients often present with shortness of... Read moreImaging IT
view channel
Ambient AI Reporting Platform Streamlines Radiology Reporting
Radiology departments face growing imaging volumes and staffing shortages, creating reporting bottlenecks and pressure to maintain turnaround times. Conventional dictation tools document findings after... Read more
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read moreIndustry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







